ADREXpharma® offers the perfect interaction between research, development and innovation of the cannabis therapy and is constantly expanding the product portfolio with an attractive pipeline of new and innovative products.
The current product portfolio consists of compounding products for prescription drugs such as cannabidiol and dronabinol, cannabis flowers and THC extracts as well as a line of natural cosmetics.
For more detailed information on our product groups, please contact our team of experts.
The AMG regulates that advertising for narcotics as pharmaceuticals is not permitted. No more detailed product descriptions may be made available to the public. Violations are a criminal offense. Therefore, our products on this website are only available for registered users after prior verification and registration.
